If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Holding(s) in Company

29 Dec 2021 07:00

RNS Number : 8557W
CIP Merchant Capital Ltd
29 December 2021
 

29 December 2021

 

CIP MERCHANT CAPITAL LIMITED

("CIP Merchant Capital" or the "Company")

 

Holding in Company

 

CIP Merchant Capital (AIM:CIP), a closed-ended investment company, announces that it was informed on 27 December 2021 that, Goldfinch SA ("Goldfinch"), a company wholly owned in equal proportion by Marco Fumagalli and Carlo Sgarbi, purchased 290,000 ordinary shares in the Company ("Ordinary Shares") (the "Share Purchase").

 

Following the Share Purchase, Goldfinch holds 4,811,527 Ordinary Shares, representing approximately 9.11 per cent. of the Company's issued capital. Accordingly, Marco Fumagalli is beneficially interested in approximately 4.37 per cent. of the Company's issued share capital and Carlo Sgarbi is beneficially interested in approximately 4.74 per cent. of the Company's issued share capital (including 200,000 Ordinary Shares held directly by Mr Sgarbi).

 

 

For further information, please contact:

 

Merchant Capital Manager Limited (Investment Manager)

Wikus Van Schalkwyk

 

+44 1481 749 363

Strand Hanson Limited (Financial & Nominated Adviser and Broker)

James Bellman / Matthew Chandler / Ritchie Balmer

+44 20 7409 3494

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUWUNRANUUUAA

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS